Portfolio company
Tribune Therapeutics AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
6 investors
Sectors
Deep Tech
About
This biopharmaceutical company develops protein-based therapies targeting the CCN protein family to treat patients with various fibrotic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.